![FDA, FTC and DOJ Enforcement of Medical Device Regulations FDA, FTC and DOJ Enforcement of Medical Device Regulations](https://www.fdanews.com/ext/resources/Book-Covers-2/BFFDEMDR-COVER.png?height=200&t=1685733565&width=200)
Home » SCHERING AG LICENSES SEGRA COMPOUND FOR OPHTHALMIC USE TO BAUSCH & LOMB
SCHERING AG LICENSES SEGRA COMPOUND FOR OPHTHALMIC USE TO BAUSCH & LOMB
Schering AG, Germany and Bausch & Lomb announced that Schering has granted an exclusive worldwide license to Bausch & Lomb to develop and market a selective glucocorticoid receptor agonist (SEGRA) for the non-systemic treatment of eye disorders.
Yahoo Finance (http://biz.yahoo.com/prnews/060918/ukm016.html?.v=58)
KEYWORDS FDAnews Drug Daily Bulletin
Upcoming Events
-
21Oct